Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator Recall
Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator Model/Catalog Number: 454008P Product Description: Greiner VACUETTE Blood Collection Tube with Lithium Heparin and Gel Separator (13 x 75 mm, 3.5ml)
FDA recall Class II
Ongoing
FDA lists this Class II recall for Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0200-2027
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Jul 29, 2026
- FDA report date
- Oct 28, 2026
- Quantity in commerce
- 860450
- Distribution
- See key details
- FDA cause
- Nonconforming Material/Component
What is being recalled?
Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator Model/Catalog Number: 454008P Product Description: Greiner VACUETTE Blood Collection Tube with Lithium Heparin and Gel Separator (13 x 75 mm, 3.5ml)
Affected model & UDI checker
Search the exact identifiers published for Z-0200-2027.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 454008P | Brand Name: VACUETTE Product Name: LH Lithium Heparin Separator | Check source notice | Not specified |
FDA code information
Lot Code: Item Number: 454008P Lot Number: B26043FM UDI: Rack: 29120017579032, Case: 39120017579039 Expiration Date: 2027-07-12
Why was this product recalled?
Lot B26043FM may include EDTA contamination which introduces potassium while chelating calcium in patient samples, leading to falsely elevated potassium (K+) and falsely decreased calcium (Ca++) results which have the potential to cause hyperkalemia.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Greiner Bio-One North America, Inc. take?
On 07/29/2026, an "URGENT MEDICAL DEVICE RECALL NOTICE" was emailed to customers informing them that, Greiner Bio-One North America identified a potential ethylenediaminetetraacetic acid (EDTA) contamination issue in a specific lot of VACUETTE Lithium Heparin serum separator tubes. Use of affected tubes may lead to: " Falsely elevated potassium (K+) results " Falsely decreased calcium (Ca++) results Customers are instructed to: " Immediately identify and quarantine all remaining units of item 454008P, lot B26043FM. " Stop using the affected lot for blood collection. " Notify relevant staff (phlebotomy, lab, clinical teams) of this advisory. " Review any recent patient results obtained using this lot. Consider repeat testing with a different lot if results appear inconsistent with clinical presentation. " Follow proper order of draw, and recollection procedures when re-testing. For unused product disposal (if destroyed by customer/distributor) " The unused blood collection tubes contain chemical additives (LH and serum separator). Recommend following OSHA process, and/or your facility's environmental health and safety (EHS) policies and procedures for disposal. For questions or documentation (Acknowledgement and Receipt Form) to [email protected] or please call 800-515-8112.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0200-2027
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 19, 2026
- openFDA device recall record · Source release Nov 14, 2026 · Retrieved Nov 19, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology